IGF-1R signaling decreases chemotherapeutic responses in breast cancer through multiple mechanisms, including promoting proliferation, enhancing cancer stemness, inhibiting apoptosis through DNA damage repair, and inducing efflux transporters [144,145]. This evidence concerns the gene IGF1R and breast cancer.